GLP-1 use in US children under 12 has surged 300% since 2019, despite lacking FDA approval. Over 20,000 kids aged 8-11 took these drugs, driven by rising obesity rates. Doctors prescribe off-label for severe cases.
GLP-1 Use in Children Under 12 Soars 300-Fold
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →